Stephen Hahn

FDA guidance eases some Covid-19 vaccine concerns, but others remain

  • by

Amid fears of a premature emergency use authorization for a Covid-19 vaccine granted for political reasons, the guidance that the FDA released at the beginning of the month sets much tougher standards. But trial enrollment, anti-vaccine sentiment and other potential problems persist.